Have your own idea? Try our Stock Screener
Chinese (SSE) Healthcare Services Industry Analysis
UpdatedJul 11, 2026
DataAggregated Company Financials
Companies42
- 7D-0.7%
- 3M-14.7%
- 1Y-17.4%
- YTD-19.6%
The Healthcare Services is pretty flat in the last 7 days, but Qingdao Baheal Medical has stood out, gaining 12%. As for the longer term, the industry has declined 17% in the last year. Looking forward, earnings are forecast to grow by 18% annually.
Industry Valuation and Performance
Has the Chinese Healthcare Services Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sun, 12 Jul 2026 | CN¥517.2b | CN¥1.1t | CN¥24.2b | 28.2x | 21.4x | 0.5x |
| Tue, 09 Jun 2026 | CN¥515.8b | CN¥1.1t | CN¥24.2b | 28.8x | 21.3x | 0.5x |
| Thu, 07 May 2026 | CN¥607.8b | CN¥1.1t | CN¥24.5b | 32.4x | 24.8x | 0.6x |
| Sat, 04 Apr 2026 | CN¥609.1b | CN¥1.1t | CN¥24.8b | 33.3x | 24.6x | 0.6x |
| Mon, 02 Mar 2026 | CN¥643.6b | CN¥1.1t | CN¥24.2b | 33.2x | 26.6x | 0.6x |
| Wed, 28 Jan 2026 | CN¥662.9b | CN¥1.1t | CN¥24.2b | 34x | 27.4x | 0.6x |
| Fri, 26 Dec 2025 | CN¥636.7b | CN¥1.1t | CN¥24.2b | 33.3x | 26.3x | 0.6x |
| Sun, 23 Nov 2025 | CN¥626.8b | CN¥1.1t | CN¥24.2b | 34.7x | 25.9x | 0.6x |
| Tue, 21 Oct 2025 | CN¥630.4b | CN¥1.1t | CN¥24.7b | 33.3x | 25.5x | 0.6x |
| Thu, 18 Sep 2025 | CN¥608.2b | CN¥989.4b | CN¥21.7b | 35.3x | 28x | 0.6x |
| Sat, 16 Aug 2025 | CN¥612.4b | CN¥988.5b | CN¥20.9b | 32.5x | 29.3x | 0.6x |
| Mon, 14 Jul 2025 | CN¥574.8b | CN¥988.6b | CN¥20.9b | 30.8x | 27.5x | 0.6x |
| Wed, 11 Jun 2025 | CN¥579.3b | CN¥988.6b | CN¥21.0b | 30.6x | 27.6x | 0.6x |
| Fri, 09 May 2025 | CN¥567.0b | CN¥991.3b | CN¥20.9b | 31.4x | 27.1x | 0.6x |
| Sun, 06 Apr 2025 | CN¥585.8b | CN¥986.3b | CN¥20.6b | 32.4x | 28.4x | 0.6x |
| Tue, 04 Mar 2025 | CN¥595.7b | CN¥994.3b | CN¥21.5b | 31.6x | 27.7x | 0.6x |
| Thu, 30 Jan 2025 | CN¥547.2b | CN¥994.3b | CN¥21.5b | 28.6x | 25.4x | 0.6x |
| Sat, 28 Dec 2024 | CN¥599.0b | CN¥994.3b | CN¥21.5b | 32.1x | 27.8x | 0.6x |
| Mon, 25 Nov 2024 | CN¥605.5b | CN¥994.3b | CN¥21.5b | 32.8x | 28.1x | 0.6x |
| Wed, 23 Oct 2024 | CN¥604.2b | CN¥985.0b | CN¥22.0b | 36.1x | 27.4x | 0.6x |
| Fri, 20 Sep 2024 | CN¥468.7b | CN¥984.5b | CN¥22.0b | 26.4x | 21.3x | 0.5x |
| Sun, 18 Aug 2024 | CN¥510.2b | CN¥988.6b | CN¥22.6b | 27.6x | 22.5x | 0.5x |
| Tue, 16 Jul 2024 | CN¥493.8b | CN¥988.5b | CN¥22.5b | 27.7x | 21.9x | 0.5x |
| Thu, 13 Jun 2024 | CN¥549.9b | CN¥988.5b | CN¥22.5b | 30.8x | 24.4x | 0.6x |
| Sat, 11 May 2024 | CN¥598.5b | CN¥988.3b | CN¥22.4b | 34.3x | 26.7x | 0.6x |
| Mon, 08 Apr 2024 | CN¥594.3b | CN¥986.0b | CN¥19.4b | 29.3x | 30.6x | 0.6x |
| Wed, 06 Mar 2024 | CN¥621.7b | CN¥977.8b | CN¥20.1b | 30x | 30.9x | 0.6x |
| Fri, 02 Feb 2024 | CN¥572.4b | CN¥976.6b | CN¥19.8b | 28.3x | 28.9x | 0.6x |
| Sun, 31 Dec 2023 | CN¥678.0b | CN¥976.1b | CN¥19.9b | 33.3x | 34x | 0.7x |
| Tue, 28 Nov 2023 | CN¥717.8b | CN¥976.1b | CN¥19.9b | 32.2x | 36x | 0.7x |
| Thu, 26 Oct 2023 | CN¥681.4b | CN¥982.3b | CN¥21.0b | 27.2x | 32.4x | 0.7x |
| Sat, 23 Sep 2023 | CN¥724.3b | CN¥982.2b | CN¥21.2b | 29.5x | 34.2x | 0.7x |
| Mon, 21 Aug 2023 | CN¥729.1b | CN¥956.6b | CN¥23.2b | 24.1x | 31.4x | 0.8x |
| Wed, 19 Jul 2023 | CN¥771.8b | CN¥948.1b | CN¥23.0b | 25.5x | 33.6x | 0.8x |
Price to Earnings Ratio
33.6x
Current Industry PE
- Investors are pessimistic on the Chinese Healthcare industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading at a PE ratio of 21.4x which is lower than its 3-year average PE of 27.7x.
- The industry is trading close to its 3-year average PS ratio of 0.60x.
Past Earnings Growth
- The earnings for companies in the Healthcare industry have remained mostly flat over the last three years.
- Meanwhile revenues for these companies have grown 5.2% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased and as a result, profits have held steady.
Industry Trends
Which industries have driven the changes within the Chinese Healthcare industry?
| CN Market | -3.19% | |
| Healthcare | -1.31% | |
| Healthcare Services | -0.71% | |
| Healthcare Distributors | -0.062% | |
| Healthcare Facilities | -1.61% | |
| Healthcare Services | -1.71% | |
Industry PE
- Investors are most optimistic about the Healthcare Facilities industry even though it's trading below its 3-year average PE ratio of 61.8x.
- Analysts are expecting annual earnings growth of 23.5%, which is higher than its past year's earnings decline of 44.6% per year.
Forecasted Growth
- Analysts are most optimistic on the Healthcare Services industry, expecting annual earnings growth of 32% over the next 5 years.
- This is better than its past earnings growth rate of 4.1% per year.
- In contrast, the Healthcare Distributors industry is expected to see its earnings grow by 12% per year over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 301015 Qingdao Baheal Medical | CN¥22.92 | 12.1% +CN¥1.3b | 8.0% | PE23.5x | |
| 000078 Shenzhen Neptunus Bioengineering | CN¥1.89 | 26.8% +CN¥1.1b | -28.9% | PS0.2x | |
| 002219 New Journey Health Technology GroupLTD | CN¥1.98 | 8.2% +CN¥516.3m | -10.4% | PE264.6x | |
| 603882 Guangzhou Kingmed Diagnostics Group | CN¥24.62 | 3.2% +CN¥352.1m | -13.1% | PS1.9x | |
| 600998 Jointown Pharmaceutical Group | CN¥5.01 | 1.4% +CN¥349.1m | -6.2% | PE12.4x |